Absence of association between a common mutation in the methylenetetrahydrofolate reductase gene and the risk of coronary artery disease

European Journal of Clinical Investigation

Volumn 28, Issue 1, 1998, Pages 20-23

  Reinhardt, D ^a   Sigusch, H H ^a   Vogt, S F ^a   Farker, K ^a   Muller S ^a   Hoffmann, A ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Coronary artery disease; Genes; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); HOMOCYSTEINE;

ALLELE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POINT MUTATION; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; GERMANY; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; RISK FACTORS;

EID: 0031950779     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1998.00242.x     Document Type: Article

References (18)

1. Gallagher PM, Meleady R, Shields DC et al. Homocystein and risk of premature coronary heart disease. Circulation, 1996; 94: 2151-2158.
2. Wu LL, Wu J, Hunt SC et al. Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease. Clinical Chemistry, 1994; 40: 550-561.
3. Daly L, Robinson K, Tan KS, Graham IM. Hyperhomocysteinemia: a metabolic risk factor for coronary heart disease determined by both genetic and environmental influences. Quarterly Journal of Medicine, 1993; 86: 685-689.
4. Boers GHJ, Smals AGH, Trijbels JMF et al. Heterozygosity for homozystinuria in premature peripheral and cerebral occlusive disease. New England Journal of Medicine, 1985; 313: 709-715.
5. Brattstrom L, Lindgren A, Israelsson B et al. Hyperhomocysteinaemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors. European Journal of Clinical Investigation, 1992; 22: 214-221.
6. Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willet WC, Stampfer MJ. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke. Stroke, 1994; 25: 1924-1930.
7. den Heijer M, Koster T, Blom HJ et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 1996; 334: 759-762.
8. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. Journal of the American Medical Association, 1995 274: 1049-1057.
9. Kang S, Passen EL, Ruggie N, Wong PWK, Hyunchoo S. thermolabile effect of methylenetetrahydrofolate reductase in coronary artery disease. Circulation, 1993; 88: 1463-1469.
10. Frosst P, Blom HJ, Milos R et al. A candidate gene risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 1995; 10: 11-113.
11. Wilcken DEL, Wilcken B. The pathogenesis of coronary artery disease: a possible role for methionine metabolism. Journal of Clinical Investigation, 1976; 57: 1079-1082.
12. Kang SS, Wong PWK, Malinow MR. Hyperhomozyst(e)inemia as a risk factor for occlusive vascular disease. Annual Review of Nutrition, 1992; 12: 279-298.
13. Malinow MR. Homozyst(e)ine and arterial occlusive diseases. Journal of Internal Medicine, 1994; 236: 603-617.
14. Ma J, Stampfer MJ, Hennekens CH et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation, 1996; 94: 2410-2416.
15. Kluijtmans LA, Van den Heuvel LPWJ, Boers GHJ et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. American Journal of Human Genetics, 1996; 58: 35-41.
16. Deloughery TG, Evans A, Sadeghi A et al. Common mutation in methylenetetrahydrofolate reductase. Circulation, 1996; 94: 3074-3078.
17. van Bockxmeer FM, Mamone CDS, Vasikaran SD, Taylor RR. Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation, 1997; 95: 21-23.
18. Schmitz C, Lindtpaintner K, Verhoef P, Gaziano JM, Buring J. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. Circulation, 1996; 94: 1812-1814.